{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T20:01:48Z","timestamp":1769803308912,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Histochem Cell Biol"],"DOI":"10.1007\/s00418-026-02457-x","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:10:50Z","timestamp":1769764250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical evaluation of acyl-CoA synthetase long-chain family member\u00a04 (ACSL4) immunoreactivity in malignant melanoma specimens"],"prefix":"10.1007","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3378-0619","authenticated-orcid":false,"given":"Mehmet Semih","family":"Celik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6384-9146","authenticated-orcid":false,"given":"F\u0131rat","family":"As\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-500X","authenticated-orcid":false,"given":"Hamza","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1499-6799","authenticated-orcid":false,"given":"Alpay","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6759-388X","authenticated-orcid":false,"given":"Candan","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1409-250X","authenticated-orcid":false,"given":"Nagehan","family":"Cepik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1323-640X","authenticated-orcid":false,"given":"G\u00fcl Ebru","family":"Aydeniz Acar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1050-9217","authenticated-orcid":false,"given":"Mehmet","family":"\u00d6lmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5206-3734","authenticated-orcid":false,"given":"Serhat","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8196-7470","authenticated-orcid":false,"given":"\u00d6mer","family":"Karakoyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2457_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03190-9","volume":"25","author":"D Cao","year":"2023","unstructured":"Cao D, Zheng J, Li Z, Yu Y, Chen Z, Wang Q (2023) ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model. Arthritis Res Ther 25:212","journal-title":"Arthritis Res Ther"},{"key":"2457_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110629","volume":"122","author":"P Chen","year":"2023","unstructured":"Chen P, Wang D, Xiao T, Gu W, Yang H, Yang M et al (2023) ACSL4 promotes ferroptosis and M1 macrophage polarization to regulate the tumorigenesis of nasopharyngeal carcinoma. Int Immunopharmacol 122:110629","journal-title":"Int Immunopharmacol"},{"key":"2457_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbi.2021.01.003","volume":"93","author":"Y Cui","year":"2021","unstructured":"Cui Y, Zhang Y, Zhao X, Shao L, Liu G, Sun C et al (2021) ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation. Brain Behav Immun 93:312\u2013321","journal-title":"Brain Behav Immun"},{"key":"2457_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310227","volume":"11","author":"J Cui","year":"2024","unstructured":"Cui J, Chen Y, Yang Q, Zhao P, Yang M, Wang X et al (2024) Protosappanin A protects DOX-induced myocardial injury and cardiac dysfunction by targeting ACSL4\/FTH1 axis-dependent ferroptosis. Adv Sci 11:e2310227","journal-title":"Adv Sci"},{"key":"2457_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/pcmr.13149","volume":"37","author":"D Dias","year":"2024","unstructured":"Dias D, Louphrasitthiphol P, Goding CR (2024) TFE3 promotes ferroptosis in melanoma. Pigment Cell Melanoma Res 37:286\u2013290","journal-title":"Pigment Cell Melanoma Res"},{"key":"2457_CR6","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","volume":"136","author":"K Ding","year":"2023","unstructured":"Ding K, Liu C, Li L, Yang M, Jiang N, Luo S et al (2023) Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism. Chin Med J (Engl) 136:2521\u20132537","journal-title":"Chin Med J (Engl)"},{"key":"2457_CR7","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1080\/15384101.2020.1806426","volume":"19","author":"M Gagliardi","year":"2020","unstructured":"Gagliardi M, Saverio V, Monzani R, Ferrari E, Piacentini M, Corazzari M (2020) Ferroptosis: a new unexpected chance to treat metastatic melanoma? Cell Cycle 19:2411\u20132425","journal-title":"Cell Cycle"},{"key":"2457_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01067-y","volume":"7","author":"Y He","year":"2022","unstructured":"He Y, Dong Y, Chen Y, Zhang G, Zhang H, Lei G et al (2022) Multi-omics characterization and therapeutic liability of ferroptosis in melanoma. Signal Transduct Target Ther 7:268","journal-title":"Signal Transduct Target Ther"},{"key":"2457_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12964-023-01296-w","volume":"21","author":"K Khorsandi","year":"2023","unstructured":"Khorsandi K, Esfahani H, Ghamsari SK, Lakhshehei P (2023) Targeting ferroptosis in melanoma: cancer therapeutics. Cell Commun Signal 21:337","journal-title":"Cell Commun Signal"},{"issue":"8","key":"2457_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41423-022-00883-0","volume":"19","author":"J Luoqian","year":"2022","unstructured":"Luoqian J, Yang W, Ding X, Tuo QZ, Xiang Z, Zheng Z, Guo YJ, Li L, Guan P, Ayton S, Dong B, Zhang H, Hu H, Lei P (2022) Ferroptosis\npromotes T-cell activation-induced neurodegeneration in multiple sclerosis. Cell Mol Immunol 19(8):913\u2013924","journal-title":"Cell Mol Immunol"},{"key":"2457_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/biology10030184","volume":"10","author":"JY Lee","year":"2021","unstructured":"Lee JY, Kim WK, Bae KH, Lee SC, Lee EW (2021) Lipid metabolism and ferroptosis. Biology 10:184","journal-title":"Biology"},{"key":"2457_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2022.109488","volume":"734","author":"H Liu","year":"2023","unstructured":"Liu H, Zhao Z, Yan M, Zhang Q, Jiang T, Xue J (2023) Calycosin decreases cerebral ischemia\/reperfusion injury by suppressing ACSL4-dependent ferroptosis. Arch Biochem Biophys 734:109488","journal-title":"Arch Biochem Biophys"},{"key":"2457_CR12","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.21037\/tcr-24-1506","volume":"14","author":"J Ma","year":"2025","unstructured":"Ma J, Cai Y, Lu Y, Fang X (2025) Analysis and assessment of ferroptosis-related gene signatures and prognostic risk models in skin cutaneous melanoma. Transl Cancer Res 14:1857\u20131873","journal-title":"Transl Cancer Res"},{"key":"2457_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110215","volume":"119","author":"G Manzari Tavakoli","year":"2023","unstructured":"Manzari Tavakoli G, Mirzapour MH, Razi S, Rezaei N (2023) Targeting ferroptosis as a cell death pathway in melanoma: from molecular mechanisms to skin cancer treatment. Int Immunopharmacol 119:110215","journal-title":"Int Immunopharmacol"},{"key":"2457_CR14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jid.2024.11.007","volume":"145","author":"Y Meng","year":"2025","unstructured":"Meng Y, Zhou Q, Dian Y, Zeng F, Deng G, Chen X (2025) Ferroptosis: a targetable vulnerability for melanoma treatment. J Invest Dermatol 145:1323\u20131344","journal-title":"J Invest Dermatol"},{"key":"2457_CR15","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1002\/cam4.4706","volume":"11","author":"S Ping","year":"2022","unstructured":"Ping S, Wang S, Zhao Y, He J, Li G, Li D et al (2022) Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma. Cancer Med 11:3529\u20133541","journal-title":"Cancer Med"},{"key":"2457_CR16","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.3390\/ijms22126395","volume":"22","author":"S Strashilov","year":"2021","unstructured":"Strashilov S, Yordanov A (2021) Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances. Int J Mol Sci 22:6395","journal-title":"Int J Mol Sci"},{"key":"2457_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1252567","volume":"14","author":"N Ta","year":"2023","unstructured":"Ta N, Jiang X, Zhang Y, Wang H (2023) Ferroptosis as a promising therapeutic strategy for melanoma. Front Pharmacol 14:1252567","journal-title":"Front Pharmacol"},{"key":"2457_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/pcmr.13009","volume":"35","author":"R Talty","year":"2022","unstructured":"Talty R, Bosenberg M (2022) The role of ferroptosis in melanoma. Pigment Cell Melanoma Res 35:18\u201325","journal-title":"Pigment Cell Melanoma Res"},{"key":"2457_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102262","volume":"51","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang M, Bi R, Su Y, Quan F, Lin Y et al (2022) ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury. Redox Biol 51:102262","journal-title":"Redox Biol"},{"key":"2457_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41401-023-01156-w","volume":"45","author":"B Wang","year":"2024","unstructured":"Wang B, Yang LN, Yang LT, Liang Y, Guo F, Fu P et al (2024) Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis. Acta Pharmacol Sin 45:150\u2013165","journal-title":"Acta Pharmacol Sin"},{"key":"2457_CR21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202402285R","volume":"39","author":"H Wang","year":"2025","unstructured":"Wang H, Qiao S, Huang L, Zhang Z, Wang J, Tian W (2025a) PTPN9 promotes melanoma progression by regulating the ferroptosis pathway. FASEB J 39:e70394","journal-title":"FASEB J"},{"key":"2457_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cell.2024.10.047","volume":"188","author":"Y Wang","year":"2025","unstructured":"Wang Y, Hu M, Cao J, Wang F, Han JR, Wu TW et al (2025b) ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization. Cell 188:412-429.e27","journal-title":"Cell"},{"key":"2457_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024866","volume":"100","author":"X Wu","year":"2021","unstructured":"Wu X, Zhao J (2021) Novel oxidative stress-related prognostic biomarkers for melanoma associated with tumor metastasis. Medicine (Baltimore) 100:e24866","journal-title":"Medicine (Baltimore)"},{"key":"2457_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07098-3","volume":"15","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhao Z, Li B, Huan S, Li Z, Xie J et al (2024) ACSL4-mediated lipid rafts prevent membrane rupture and inhibit immunogenic cell death in melanoma. Cell Death Dis 15:695","journal-title":"Cell Death Dis"}],"container-title":["Histochemistry and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-026-02457-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00418-026-02457-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-026-02457-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:10:53Z","timestamp":1769764253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00418-026-02457-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2457"],"URL":"https:\/\/doi.org\/10.1007\/s00418-026-02457-x","relation":{},"ISSN":["1432-119X"],"issn-type":[{"value":"1432-119X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was performed using de-identified archival biopsy materials. In line with institutional regulations and with the authorization of the Ethics Committee of Gazi Ya\u015fargil Training and Research Hospital (Approval No. 578\/2025), obtaining written informed consent from patients was not necessary. The ethics committee officially granted a waiver for the informed consent requirement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"7"}}